United Kingdom Over The Counter (OTC) Drugs Market, By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027
United Kingdom over-the-counter (OTC) drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to surging demands for cold & flu medicines. Higher prices of branded drugs along with the growing prevalence of infectious diseases further drive the growth of the United Kingdom over the country (OTC) drugs market in the upcoming five years. Consistent research and advancement of the pharmaceutical industry coupled with the local manufacturing of generic drugs also supports the growth of the United Kingdom over-the-counter (OTC) drugs market in the next five years.
Over-the-counter, (OTC) drugs are non-prescription-based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without a physician’s prescription. Although, as a general awareness physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over-the-counter (OTC) drugs.
Expanding Pharmaceutical Industry Promises Market Growth
A surge in the demand for advanced medicine at affordable prices drives the growth of the United Kingdom over-the-counter (OTC) drugs market in the upcoming five years. In 2019, the annual turnover of pharmaceutical goods wholesalers in the UK was over USD63 billion. The pharmaceutical industry holds a position among the top 10 global industries for pharmaceutical products that accounts for over 2.5% of the global market. Imports of pharmaceutical products from other countries have considerably decreased in 2020 valued at USD20,871 million from USD23,458 million in the year 2019. Decreased imports point to increased research and development along with the growing inclination of consumers toward over-the-counter (OTC) drugs, thereby substantially supporting the growth of the United Kingdom over-the-counter (OTC) drugs market in the next five years.
Investments and Expenses Drives Market
Growing investments and rising expenses over the pharmaceutical products and therapeutics in the country further support the growth of the United Kingdom over-the-counter (OTC) drugs market in the future five years. The government is actively investing in the pharmaceutical industry to promote local manufacturers along with rising expenditures by the consumers demanding advanced & affordable pharmaceutical products, thereby aiding the growth of the United Kingdom over-the-counter (OTC) drugs market in the forecast years.
Market Segmentation
In the United Kingdom the counter (OTC) drugs market is segmented by product, route of administration, dosage form, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into a cough, cold, and flu; vitamins, minerals, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. By route of administration, the market is fragmented into oral, topical, and parenteral. Based on dosage form, the market is differentiated into tablets, capsules, liquids & solutions, creams/lotions/ointments, and others. Based on distribution channels, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.
Company Profile
GlaxoSmithKline Plc., Novartis UK Limited, Sun Pharmaceuticals UK Limited, Johnson & Johnson Limited, Perrigo Company Plc., Reckitt Benckiser Plc., AstraZeneca Plc., among others is a partial list of major market players of the companies responsible for the growth of United Kingdom over the counter (OTC) drugs market.
Report Scope:
In this report, United Kingdom over-the-counter (OTC) drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in United Kingdom over the counter (OTC) drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Over-the-counter, (OTC) drugs are non-prescription-based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without a physician’s prescription. Although, as a general awareness physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over-the-counter (OTC) drugs.
Expanding Pharmaceutical Industry Promises Market Growth
A surge in the demand for advanced medicine at affordable prices drives the growth of the United Kingdom over-the-counter (OTC) drugs market in the upcoming five years. In 2019, the annual turnover of pharmaceutical goods wholesalers in the UK was over USD63 billion. The pharmaceutical industry holds a position among the top 10 global industries for pharmaceutical products that accounts for over 2.5% of the global market. Imports of pharmaceutical products from other countries have considerably decreased in 2020 valued at USD20,871 million from USD23,458 million in the year 2019. Decreased imports point to increased research and development along with the growing inclination of consumers toward over-the-counter (OTC) drugs, thereby substantially supporting the growth of the United Kingdom over-the-counter (OTC) drugs market in the next five years.
Investments and Expenses Drives Market
Growing investments and rising expenses over the pharmaceutical products and therapeutics in the country further support the growth of the United Kingdom over-the-counter (OTC) drugs market in the future five years. The government is actively investing in the pharmaceutical industry to promote local manufacturers along with rising expenditures by the consumers demanding advanced & affordable pharmaceutical products, thereby aiding the growth of the United Kingdom over-the-counter (OTC) drugs market in the forecast years.
Market Segmentation
In the United Kingdom the counter (OTC) drugs market is segmented by product, route of administration, dosage form, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into a cough, cold, and flu; vitamins, minerals, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. By route of administration, the market is fragmented into oral, topical, and parenteral. Based on dosage form, the market is differentiated into tablets, capsules, liquids & solutions, creams/lotions/ointments, and others. Based on distribution channels, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.
Company Profile
GlaxoSmithKline Plc., Novartis UK Limited, Sun Pharmaceuticals UK Limited, Johnson & Johnson Limited, Perrigo Company Plc., Reckitt Benckiser Plc., AstraZeneca Plc., among others is a partial list of major market players of the companies responsible for the growth of United Kingdom over the counter (OTC) drugs market.
Report Scope:
In this report, United Kingdom over-the-counter (OTC) drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United Kingdom Over The Counter (OTC) Drugs Market, By Product:
- Cough, Cold, and Flu
- Vitamins, Mineral, and Supplements (VMS)
- Analgesics
- Gastrointestinal Products
- Dermatology Products
- Others
- United Kingdom Over The Counter (OTC) Drugs Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- United Kingdom Over The Counter (OTC) Drugs Market, By Dosage Form:
- Tablets
- Capsules
- Liquids & Solution
- Creams/ Lotions/ Ointments
- Others
- United Kingdom Over The Counter (OTC) Drugs Market, By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
- United Kingdom Over The Counter (OTC) Drugs Market, By Region:
- London
- East Anglia
- Southwest
- Southeast
- Scotland
- East Midlands
- Yorkshire & Humberside
Company Profiles: Detailed analysis of the major companies present in United Kingdom over the counter (OTC) drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UNITED KINGDOM OVER-THE-COUNTER (OTC) DRUGS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMERS
6. UNITED KINGDOM OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UNITED KINGDOM COUGH, COLD AND FLU OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. UNITED KINGDOM VITAMINS, MINERAL AND SUPPLEMENTS (VMS) OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
9. UNITED KINGDOM ANALGESICS OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
10. UNITED KINGDOM GASTROINTESTINAL OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
11. UNITED KINGDOM DERMATOLOGY OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. POLICY & REGULATORY LANDSCAPE
15. UNITED KINGDOM ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. GlaxoSmithKline Plc.
16.2. Novartis UK Limited
16.3. Sun Pharmaceuticals UK Limited
16.4. Johnson & Johnson Limited
16.5. Perrigo Company Plc.
16.6. Reckitt Benckiser Plc.
16.7. AstraZeneca Plc.
17. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UNITED KINGDOM OVER-THE-COUNTER (OTC) DRUGS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMERS
6. UNITED KINGDOM OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UNITED KINGDOM COUGH, COLD AND FLU OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. UNITED KINGDOM VITAMINS, MINERAL AND SUPPLEMENTS (VMS) OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
9. UNITED KINGDOM ANALGESICS OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
10. UNITED KINGDOM GASTROINTESTINAL OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
11. UNITED KINGDOM DERMATOLOGY OVER-THE-COUNTER (OTC) DRUGS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. POLICY & REGULATORY LANDSCAPE
15. UNITED KINGDOM ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. GlaxoSmithKline Plc.
16.2. Novartis UK Limited
16.3. Sun Pharmaceuticals UK Limited
16.4. Johnson & Johnson Limited
16.5. Perrigo Company Plc.
16.6. Reckitt Benckiser Plc.
16.7. AstraZeneca Plc.
17. STRATEGIC RECOMMENDATIONS
